MedTrace Logo

Antibiotic Prophylaxis With Routine Ureteral Stent Removal

NCT02944825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-03-04

No results posted yet for this study

Summary

This study will be a single-institutional randomized, single-blinded prospectively controlled clinical trial of a single dose of Ciprofloxicin 500mg antibiotic tablet as prophylaxis at the time of office flexible cystoscopy with ureteral stent removal. The control group will be no prophylaxis oral antibiotics.

Conditions

  • Urolithiasis
  • UTI

Interventions

DRUG

Ciprofloxacin

first line prophylactic oral antibiotic

DRUG

trimethoprim/sulfamethoxazole

second line prophylactic oral antibiotic

DRUG

No Intervention

No intervention

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2025-01-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02944825 on ClinicalTrials.gov